Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Krystal Biotech (KRYS) Inventory Average (2023 - 2025)

Krystal Biotech's Inventory Average history spans 3 years, with the latest figure at $39.1 million for Q4 2025.

  • For Q4 2025, Inventory Average rose 73.23% year-over-year to $39.1 million; the TTM value through Dec 2025 reached $39.1 million, up 73.23%, while the annual FY2025 figure was $33.5 million, 99.99% up from the prior year.
  • Inventory Average for Q4 2025 was $39.1 million at Krystal Biotech, up from $28.2 million in the prior quarter.
  • Across five years, Inventory Average topped out at $39.1 million in Q4 2025 and bottomed at $6.1 million in Q4 2023.
  • The 3-year median for Inventory Average is $22.5 million (2024), against an average of $22.3 million.
  • The largest annual shift saw Inventory Average surged 267.68% in 2024 before it soared 73.23% in 2025.
  • A 3-year view of Inventory Average shows it stood at $6.1 million in 2023, then soared by 267.68% to $22.5 million in 2024, then skyrocketed by 73.23% to $39.1 million in 2025.
  • Per Business Quant, the three most recent readings for KRYS's Inventory Average are $39.1 million (Q4 2025), $28.2 million (Q1 2025), and $22.5 million (Q4 2024).